Articles on Drug prices

Displaying all articles

The cells inside this bioreactor are the real pharmaceutical factories. Sanofi Pasteur

Biologics: The pricey drugs transforming medicine

Rather than being designed by chemists, this class of pharmaceuticals is produced by living cells. Here's where they come from and how they work.
New Zealand shows up Australia as badly in the field of pharmaceuticals as it does on the rugby field. Dave Hunt/AAP

New Zealand steamrolls Australia on the pharmaceutical paddock too

Drug prices in Australia are three times higher than in New Zealand. A key reason is the lack of transparency about taxpayer subsidies for Big Pharma and the companies' own finances.
Some of the notable additions to the PBS include drugs to treat eye and HIV infections, cystic fibrosis, multiple sclerosis, and cancer. from shutterstock.com

New drugs on the PBS: what they do and why we need them

An independent expert provides his pick of the most notable drugs added to the PBS on May 1, 2017.
The government is paying too much for pharmaceuticals that are no better than their cheaper counterparts. Let’s fix that. from www.shutterstock.com

How to slash half a billion dollars a year from Australia’s drugs bill

Australia is spending more than A$500 million a year too much for pharmaceuticals because of a little known loophole that allows drug companies to overcharge the government.
The rising costs of EpiPens has led to outrage. Rich Pedroncelli/AP

Drug prices: Where do we go after the Election?

The rising cost of drugs is more worrisome to most Americans than problems with Obamacare. Could proposals in California and Ohio help?
The PBAC must make tough decisions about which cancer drugs to subsidise. Eric Gaillard/Reuters

New cancer drugs are very expensive - here’s how we work out value for our money

Most of us would agree that cancer drugs should be listed on the PBS, no matter how dear. But our health system can't afford all of them. How then are decisions about which drugs to subsidise made?
Trade minister Andrew Robb attends negotiations for the Trans Pacific Partnership in Sydney last year. Dan Himbrechts/AAP Image

How the battle over biologics helped stall the Trans Pacific Partnership

Over the next few weeks, the trade minister will be under intense pressure to renege on the government’s commitment to reject anything in the Trans Pacific Partnership that could undermine the PBS.
A group of oncologists have called on cancer patients to challenge the high prices charged by pharmaceutical companies for new cancer drugs. ep_jhu/Flickr

If we don’t talk about value, cancer drugs will become terminal for health systems

Hope, fear, and desperation, along with the unique characteristics of the cancer drug market, create a “perfect storm” that continues to drive up prices for cancer drugs.

Top contributors

More